Einsof Biohealth™ is a biotech company focused on the discovery, development, and commercialization of novel, proprietary therapies and OTC products.
Our developments stem from our proprietary platform of encapsulating active ingredients with an innovative delivery mechanism to enhance pathways to superior solutions. Our fully patented technology has so many derivatives that our pipeline ranges from developments for diabetics to probiotics.
Our liposomal technology represents a superior transport system when compared to traditional ones, as it delivers the active ingredients without gastric juices acting on and compromising the integrity, strength or structure of the active pharmaceutical ingredient.
Speedlyte: Technology Applied to Dehydration Problem
Using nano-biotechnology, at Einsof Biohealth™, electrolytes are encapsulated into natural biocompatible nano-particles that release electrolytes in a gradual and controlled way into the intestine. The result of this “Encapsulated Nano-Electrolytes™” generates electrolytes with three very distinctive benefits:
Unlike regular electrolytes that are dissolved into water, our electrolytes are encapsulated in nano particles first.
Thanks to their encapsulation, we avoid the salty flavor of the electrolytes or the need to mask them with sugars and sweeteners, resulting in a much better taste. For example, Speedlyte™ contains only 15 grams of sugar per liter, compared with 60 grams in sport drinks.
Unlike regular electrolytes, the Encapsulated Nano-Electrolytes™ travel much faster through the body and into the small intestine. Once there, they release the electrolytes in a controlled way, resulting in up to 70% higher body absorption and liquid retention.
Higher absorption means it may take up to one third of the time to recover the lost of fluids and restore body weight than with alternative treatments.
In turn, higher absorption and appropriate osmolality level leads to less intake, up to 40% less intake to be more precise. Thus, under the same level of electrolytes, 20fl oz of Speedlyte™ equals up to 33.8fl oz of other products and treatments.
The technology is a patent-pending propriety exclusive of Einsof Biohealth™ Limited.
Close up picture of an Encapsulated Nano-Electrolyte™.
Pre-Clinical Trial Results
The claims of Einsof Biohealth™ superior rehydration through its Encapsulated Nano-Electrolytes™ technology is substantiated by a pre-clinical trial described below.
- An animal model of osmotic diarrhea induced by cathartics as per Wapnir et al., 1988,1991 (American Journal of Clinical Nutrition 1988; 47:84-90)
- Group 1 -in blue- received Speedlyte™ formulation with Encapsulated Nano-Electrolytes™ and Group 2 –in red- received an Oral Electrolyte Solution with non-encapsulated electrolytes.
- A total of 125ml/kg/day of doses was provided over 12 hours, with equivalent doses given every hour.
Speedlyte™ rehydrates in up to one third of the time
Comparison based on a private pre-clinical study conducted by CMC based on an induced osmatic diarrhea. A 125ml/Kg/day of product was administered in 12 doses along 12 hours. For more information please request access or contact us.